Phreesia, Inc. (NYSE:PHR) Short Interest Up 47.7% in April

Phreesia, Inc. (NYSE:PHRGet Rating) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totalling 2,570,000 shares, an increase of 47.7% from the March 31st total of 1,740,000 shares. Approximately 5.3% of the shares of the stock are short sold. Based on an average daily trading volume, of 520,400 shares, the days-to-cover ratio is presently 4.9 days.

A number of analysts recently weighed in on PHR shares. JPMorgan Chase & Co. decreased their price target on Phreesia from $51.00 to $42.00 in a research note on Thursday, March 31st. Citigroup decreased their price target on Phreesia from $54.00 to $36.00 and set a “neutral” rating on the stock in a research note on Thursday, March 31st. Piper Sandler reduced their price objective on Phreesia from $54.00 to $42.00 in a report on Monday, April 4th. JMP Securities reduced their price objective on Phreesia from $70.00 to $50.00 and set a “market outperform” rating for the company in a report on Thursday, March 31st. Finally, Canaccord Genuity Group reduced their price objective on Phreesia from $81.00 to $49.00 in a report on Thursday, March 31st. Four equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $50.00.

Shares of NYSE PHR traded down $1.04 during trading on Friday, reaching $22.88. The company had a trading volume of 752,808 shares, compared to its average volume of 516,147. Phreesia has a twelve month low of $22.54 and a twelve month high of $76.10. The stock has a market capitalization of $1.17 billion, a PE ratio of -9.82 and a beta of 1.36. The stock has a 50-day moving average price of $27.81 and a two-hundred day moving average price of $41.46. The company has a current ratio of 5.65, a quick ratio of 5.65 and a debt-to-equity ratio of 0.02.

Phreesia (NYSE:PHRGet Rating) last released its earnings results on Wednesday, March 30th. The company reported ($0.70) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($1.03) by $0.33. The firm had revenue of $58.02 million during the quarter, compared to analyst estimates of $56.34 million. Phreesia had a negative return on equity of 25.34% and a negative net margin of 55.41%. The business’s quarterly revenue was up 38.8% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.18) earnings per share. On average, sell-side analysts predict that Phreesia will post -4.07 EPS for the current year.

A number of institutional investors have recently added to or reduced their stakes in the stock. UBS Group AG increased its stake in Phreesia by 4.9% in the third quarter. UBS Group AG now owns 3,350 shares of the company’s stock valued at $207,000 after purchasing an additional 155 shares during the last quarter. Raymond James Financial Services Advisors Inc. grew its position in Phreesia by 3.0% during the third quarter. Raymond James Financial Services Advisors Inc. now owns 6,935 shares of the company’s stock valued at $428,000 after acquiring an additional 201 shares during the period. Arizona State Retirement System grew its position in Phreesia by 2.4% during the third quarter. Arizona State Retirement System now owns 12,378 shares of the company’s stock valued at $764,000 after acquiring an additional 293 shares during the period. O Shaughnessy Asset Management LLC grew its position in Phreesia by 18.6% during the third quarter. O Shaughnessy Asset Management LLC now owns 2,121 shares of the company’s stock valued at $131,000 after acquiring an additional 332 shares during the period. Finally, Oppenheimer Asset Management Inc. grew its position in Phreesia by 4.3% during the fourth quarter. Oppenheimer Asset Management Inc. now owns 9,973 shares of the company’s stock valued at $416,000 after acquiring an additional 414 shares during the period. Hedge funds and other institutional investors own 96.10% of the company’s stock.

Phreesia Company Profile (Get Rating)

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments.

See Also

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.